Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan.
about
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaeditDihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaThe effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient dataAntimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertaintiesDoes the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More Than Artemether-Lumefantrine?Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.Artemether-lumefantrine: an option for malaria.Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malariapfmdr1 amplification is related to increased Plasmodium falciparum in vitro sensitivity to the bisquinoline piperaquineEfficacy of artemether-lumefantrine as a treatment for uncomplicated Plasmodium vivax malaria in eastern SudanEx vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies.The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Coartem(®): a decade of patient-centric malaria management.Efficacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis.
P2860
Q21032449-8ABB7AFC-53DE-417F-9AD9-8859180B9D73Q24201077-AE711AAC-DDF8-45A5-AA91-ACDEF2C42584Q26822489-82AE6A95-B348-4E80-B3C9-0BCC0C5432EBQ26866187-A262DF0A-52B6-4D46-9B0E-AC78630804A5Q33874069-4397C9AC-92F5-453A-ABCF-331048707DEDQ34227179-F9DE87CE-0BEC-423D-8C05-0C3BFC092653Q34267667-51711957-1AF5-4F63-A9F3-BD93C5F34D3AQ35137471-2181F15B-28A0-4C21-BA43-8469523AB190Q36080121-378DC5CC-F56C-4A69-A578-2D4B257CAC5FQ36086426-EE4DA81F-197A-448A-89A2-12470836AB39Q36459402-2740EBCF-8DBB-4BB6-9195-1817E7209579Q37263344-694AE238-1DA5-4348-B427-BDDCBB883F0EQ38065917-F62DDBE6-3788-4460-85CC-67F806AA4EDDQ38529669-D375BB2C-915F-419C-9886-A9E75DD5E7DAQ39042892-E068C085-60C2-4B4A-B601-CD7F01862F52Q53702337-0C0C833A-2B6E-4901-BD5A-CA8E291E6D1E
P2860
Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Dihydroartemisinin-piperaquine ...... arum malaria in central Sudan.
@en
Dihydroartemisinin-piperaquine ...... arum malaria in central Sudan.
@nl
type
label
Dihydroartemisinin-piperaquine ...... arum malaria in central Sudan.
@en
Dihydroartemisinin-piperaquine ...... arum malaria in central Sudan.
@nl
prefLabel
Dihydroartemisinin-piperaquine ...... arum malaria in central Sudan.
@en
Dihydroartemisinin-piperaquine ...... arum malaria in central Sudan.
@nl
P2093
P2860
P921
P1476
Dihydroartemisinin-piperaquine ...... arum malaria in central Sudan.
@en
P2093
P2860
P304
P356
10.1179/136485910X12743554760144
P577
2010-06-01T00:00:00Z